chlorophyll derivatives

Chlorophyll derivatives are plant-derived small molecules being developed by Wuhan United Pharmacy for the treatment of microcirculation disorders. These compounds are specifically researched for their potential to improve microvascular parameters in muscle, mesenteric, and ear tissues. While Wuhan United Pharmacy markets Shengxuening (a sodium iron chlorophyllin product) for iron deficiency anemia, this specific chlorophyll derivative asset is a distinct research-stage program focused on microcirculatory health. The exact molecular mechanism of action has not been publicly disclosed, but the program is part of the company's focus on modernizing Traditional Chinese Medicine (TCM) through plant-derived small molecule extracts.

Other names

叶绿素衍生物